Read More

Aurinia Pharmaceuticals Announced Departure of Executive Vice President, Research and Chief Medical Officer

On October 17, 2022, Aurinia Pharmaceuticals Inc. and Robert Huizinga, PhD RN, CNeph(C), our Executive Vice President, Research and Neil Solomons, M.D., our ChiefMedical Officer, mutually agreed that Dr. Huizinga and Dr. Solomons would cease their employment with Aurinia, each effective October 31, 2022.We expect to enter into separation agreements with Dr. Huizinga and Dr.

AUPH